Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > Dr. Jacqueline Shan vs. Dr. Foster......
View:
Post by ISAloser247 on Aug 30, 2011 11:32am

Dr. Jacqueline Shan vs. Dr. Foster......

...with Valient Pharma riding in on a white steed,   the question of Who is the better, more competent / intelligent

and obviously more RESPECTABLE Edmonton-based pharma CEO is obvious! While Dr. Shan laboured to

get a product to market, overcoming many naysayers( mortgaging her home), Dr.s Foster and Butterworth

jetted around the world,on shareholders equity and in the end, NOTHING! Dr. Shan is a success, while the

other two are laughing-stock failures!( although still cocky and arrogant) Could be a case study for TEC-Edmonton,

How to scam and blow hundreds of millions without any benefit to shareholders / society, except of course your

own ( and family's) bank accounts. HONESTY, INTEGRITY!  KHARMA IS AROUND THE CORNER!
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities